| Discipline | Ophthalmology |
|---|---|
| Language | English |
| Edited by | Stephen McLeod |
| Publication details | |
| History | 1978–present |
| Publisher | |
| Frequency | Monthly |
| 12.079 (2020) | |
| Standard abbreviations | |
| ISO 4 | Ophthalmology |
| Indexing | |
| CODEN | OPHTDG |
| ISSN | 0161-6420 (print) 1549-4713 (web) |
| LCCN | 78005685 |
| OCLC no. | 03661682 |
| Links | |
Ophthalmology is a monthly peer-reviewed medical journal published by Elsevier on behalf of the American Academy of Ophthalmology. It covers all aspects of ophthalmology.
The following persons are or have been editor-in-chief:
On June 6, 2016, The American Academy of Ophthalmology announced plans to launch Ophthalmology Retina as an extension of the journal Ophthalmology. [1] This new journal was planned in response to the growing volume of research within the retina subspecialty of ophthalmology, and will be a print and online publication.
Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders.
Retinopathy is any damage to the retina of the eyes, which may cause vision impairment. Retinopathy often refers to retinal vascular disease, or damage to the retina caused by abnormal blood flow. Age-related macular degeneration is technically included under the umbrella term retinopathy but is often discussed as a separate entity. Retinopathy, or retinal vascular disease, can be broadly categorized into proliferative and non-proliferative types. Frequently, retinopathy is an ocular manifestation of systemic disease as seen in diabetes or hypertension. Diabetes is the most common cause of retinopathy in the U.S. as of 2008. Diabetic retinopathy is the leading cause of blindness in working-aged people. It accounts for about 5% of blindness worldwide and is designated a priority eye disease by the World Health Organization.
Diabetic retinopathy, is a medical condition in which damage occurs to the retina due to diabetes mellitus. It is a leading cause of blindness in developed countries.
Singapore Health Services, commonly known as SingHealth, is Singapore's largest group of healthcare institutions. The group was formed in 2000 and consists of four public hospitals, three community hospitals, five national specialty centres and a network of eight polyclinics. The Singapore General Hospital is the largest hospital in the group and serves as the flagship hospital for the cluster.
Charles Louis Schepens was an influential Belgian ophthalmologist, regarded by many in the profession as "the father of modern retinal surgery", and member of the French Resistance.
Hamid Ahmadieh is an Iranian ophthalmologist, medical scientist, and pioneer specializing on the retina of the eye. He is also the founder of Iranian Vitreoretina Society.
Marshall Miller Parks was an American ophthalmologist known to many as "the father of pediatric ophthalmology".
A macular hole is a small break in the macula, located in the center of the eye's light-sensitive tissue called the retina.
Intraocular hemorrhage is bleeding inside the eye. Bleeding can occur from any structure of the eye where there is vasculature or blood flow, including the anterior chamber, vitreous cavity, retina, choroid, suprachoroidal space, or optic disc.
The Illinois Eye & Ear Infirmary (IEEI) is a center of ophthalmology and otolaryngology research and clinical practice.
Sengamedu Srinivasa Badrinath is the Indian founder and chairman emeritus of Sankara Nethralaya, Chennai, one of India's largest charitable eye hospitals. He is an elected fellow of the National Academy of Medical Sciences. He received the Padma Bhushan, third-highest civilian award in the Republic of India in 1996. He also received many other awards, including Padma Shri and Dr. B. C. Roy Award.
Joel S. Schuman, MD, FACS is Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation and Co-Director of the Glaucoma Service at Wills Eye Hospital. Prior to this he was the Elaine Langone Professor and Vice Chair for Research in the Department of Ophthalmology at NYU Langone Medical Center, NYU Grossman School of Medicine; Professor of Biomedical Engineering and Electrical & Computer Engineering at NYU Tandon School of Engineering and Professor of Neural Science in the Center for Neural Science at NYU College of Arts and Sciences. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine 2016-2020, and was Vice Chair for Ophthalmology Research in the department 2020-2022. Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, Director of UPMC Eye Center (2003-2016) and before that was at Tufts University 1991-2003, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003). In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001.
Childhood blindness is an important contribution to the national prevalence of the disability of blindness. Blindness in children can be defined as a visual acuity of <3/60 in the eye with better vision of a child under 16 years of age. This generally means that the child cannot see an object 10 feet away, that another child could see if it was 200 feet away.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Mark S. Humayun is a Pakistani-American ophthalmologist, engineer, scientist, inventor and academic – the only ophthalmologist elected a member of both U.S. National Academies of Medicine and Engineering. He is a university professor with joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering.
Robert E. MacLaren FMedSci FRCOphth FRCS FACS VR is a British ophthalmologist who has led pioneering work in the treatment of blindness caused by diseases of the retina. He is Professor of Ophthalmology at the University of Oxford and Honorary Professor of Ophthalmology at the UCL Institute of Ophthalmology. He is a Consultant Ophthalmologist at the Oxford Eye Hospital. He is also an Honorary Consultant Vitreo-retinal Surgeon at the Moorfields Eye Hospital. MacLaren is an NIHR Senior Investigator, or lead researcher, for the speciality of Ophthalmology. In addition, he is a member of the research committee of Euretina: the European Society of Retina specialists, Fellow of Merton College, in Oxford and a Fellow of the Higher Education Academy.
Atul Kumar is an Indian ophthalmologist who is currently the Chief & Professor of Ophthalmology at Dr. Rajendra Prasad Centre for Ophthalmic Sciences (RPC-AIIMS), the national apex ophthalmic centre at All India Institute of Medical Sciences, Delhi. He was awarded the Padma Shri award in January 2007 for his services to the medical field. He specializes in vitreoretinal surgery and also heads the Vitreo-Retinal, Uvea and ROP services at RPC-AIIMS.
Alfredo Arrigo Sadun is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair at Doheny Eye Centers-UCLA and is Vice-Chair of Ophthalmology at UCLA.
Sheila Kay West is an American ophthalmologist who is the El-Maghraby Professor of Preventive Ophthalmology at the Wilmer Eye Institute. She is also the vice-chair for Research.
  | This article about a medical journal is a stub. You can help Wikipedia by expanding it. See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
